Sanofi and Regeneron announce positive topline pivotal results for carcinoma treatment
Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive topline results from a pivotal Phase 2 clinical study of…
Pharmaceuticals, Biotechnology and Life Sciences
Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive topline results from a pivotal Phase 2 clinical study of…
Hikma Pharmaceuticals PLC (rated Ba1 Moody’s / BB+ S&P, both stable) has announced that its wholly-owned US subsidiary West-Ward Pharmaceuticals…
The board of directors of Eli Lilly and Company (NYSE: LLY) today announced an 8 percent increase in its quarterly…
Kite, a Gilead Company, announced updated results from the ongoing Phase 1/2 ZUMA-3 study of KTE-C19, a CD19 chimeric antigen…
Alexion Pharmaceuticals’s data from two Phase 1b/2 studies of ALXN1210, the company’s investigational long-acting C5 complement inhibitor, in patients with…
The U.S. Food and Drug Administration (FDA) said on Monday in an announcement that an adult smoking cessation education campaign…
Premaitha Health, a leading international molecular diagnostics group focused on non-invasive prenatal testing (NIPT), announces further expansion of its European…
Eli Lilly said on Monday that Kimberly Blackwell, M.D., one of the USA’s leading breast cancer researchers, will join Lilly Oncology as…
Eli Lilly said on Monday that the U.S. Food and Drug Administration (FDA) has accepted a Biologics License Application (BLA) to review…
Juno Therapeutics, a biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer, and Celgene Corporation have additional data from the…